Видео ютуба по тегу Trial: Mindact

Mammaprint Blueprint, Updates from MINDACT 8.7 Year, & Applications in Neoadjuvant Therapy
Mammaprint Blueprint, Updates from MINDACT 8.7 Year, & Applications in Neoadjuvant Therapy
Practice-Changing Results from the MINDACT Trial
Practice-Changing Results from the MINDACT Trial
Results of the MINDACT clinical trial
Results of the MINDACT clinical trial
MINDACT Trial Design and Results in Breast Cancer
MINDACT Trial Design and Results in Breast Cancer
Dr. Melisko Reflects on Findings From the MINDACT Trial in Breast Cancer
Dr. Melisko Reflects on Findings From the MINDACT Trial in Breast Cancer
Dr. Piccart on the MINDACT Study for Early-Stage Breast Cancer
Dr. Piccart on the MINDACT Study for Early-Stage Breast Cancer
Researchers to present first outcome results from MINDACT breast cancer clinical trial
Researchers to present first outcome results from MINDACT breast cancer clinical trial
Genomic predictors for treatment selection in ER+ breast cancer: TAILORx, MINDACT, and RxPONDER
Genomic predictors for treatment selection in ER+ breast cancer: TAILORx, MINDACT, and RxPONDER
Reviewing LORELEI, mindACT and ExteNET trials in breast cancer
Reviewing LORELEI, mindACT and ExteNET trials in breast cancer
Important lessons from TAILORX, MINDACT and RX-PONDER:
Important lessons from TAILORX, MINDACT and RX-PONDER:
MINDACT long-term results: 70-gene signature MammaPrint to guide adjuvant chemotherapy use in br...
MINDACT long-term results: 70-gene signature MammaPrint to guide adjuvant chemotherapy use in br...
MINDACT: adjuvant chemotherapy in breast cancer
MINDACT: adjuvant chemotherapy in breast cancer
Updated outcomes from MINDACT
Updated outcomes from MINDACT
Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision-Making for Early-Stage,...
Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision-Making for Early-Stage,...
Using MammaPrint to select patients who may not need adjuvant chemotherapy – the results of MINDACT
Using MammaPrint to select patients who may not need adjuvant chemotherapy – the results of MINDACT
Agendia: Finding the Right Fit for Every Patient
Agendia: Finding the Right Fit for Every Patient
Reshma Mahtani, DO | Sylvester Cancer | ASCO20 Breast Cancer Reactions: MINDACT for Early Stage
Reshma Mahtani, DO | Sylvester Cancer | ASCO20 Breast Cancer Reactions: MINDACT for Early Stage
Ruta Rao, MD | Rush University | ASCO20 Breast Cancer Reactions: MINDACT for Early Stage
Ruta Rao, MD | Rush University | ASCO20 Breast Cancer Reactions: MINDACT for Early Stage
Cancer Topics - ASCO Guidelines: Role of Patient and Disease Factors in Adjuvant Systemic Therapy...
Cancer Topics - ASCO Guidelines: Role of Patient and Disease Factors in Adjuvant Systemic Therapy...
Do I Need Chemo for Early Breast Cancer?
Do I Need Chemo for Early Breast Cancer?
Jennifer Crozier, MD | Baptist MD Anderson | ASCO20 Breast Cancer Reactions: MINDACT for Early Stage
Jennifer Crozier, MD | Baptist MD Anderson | ASCO20 Breast Cancer Reactions: MINDACT for Early Stage
MammaPrint genetic testing reduces chemotherapy overtreatment in breast cancer patients
MammaPrint genetic testing reduces chemotherapy overtreatment in breast cancer patients
New Data on Role of Gene Assays in Breast Cancer Treatment - Medpage Today
New Data on Role of Gene Assays in Breast Cancer Treatment - Medpage Today
Ranju Gupta, MD | Lehigh Valley Health | ASCO20 Breast Cancer Reactions: MINDACT for Early Stage
Ranju Gupta, MD | Lehigh Valley Health | ASCO20 Breast Cancer Reactions: MINDACT for Early Stage
Returning to Standard Therapy After a Clinical Trial
Returning to Standard Therapy After a Clinical Trial